Through our core technical capabilities in modern traditional Chinese medicine (TCM) and advanced controlled-release formulations, Baheal Medical has established a sophisticated R&D and production system for both TCM and chemical medicines. We have successfully launched a variety of innovative products with proprietary intellectual property rights, and consistently drive forward technological development and production for upstream medical innovations.

Shanghai - Modern TCM R&D and Production Base

As a modern TCM R&D and manufacturing platform, it aims to inherit and promote traditional Chinese medicine. With modernization, standardization, and globalization of TCM as its mission, it adheres to the concept of diagnosable diseases, controllable quality, and traceable efficacy, building a full industrial chain of modern TCM.

25400

Land Area

25.9 Billion tablets

Annual production capacity

Qingdao - Advanced Controlled-release Formulation R&D and Production Base

As an advanced controlled-release formulation R&D and manufacturing platform, it focuses on the R&D and commercial production of advanced formulation technologies such as osmotic pumps and pellet coating matrix tablets. 


 

  • cGMP Certification by FDA

  • "Zero Defect", Co-production and sales in China and the USA

85600

Land Area

65 Billion tablets

Annual production capacity

Back to Top